{
  "docId": "019de071-41d7-735b-bdce-76898f0847d2",
  "docSlug": "eaafde7daeccaea38d88b7264ade91c5",
  "documentTitle": "Erasca | IPO Presentation Deck | 46 slides",
  "authorId": "erasca",
  "authorName": "Erasca",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 46,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "mission",
  "function": "inspire_vision",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "The slide combines mission statement, company history, pipeline milestones, and investor logos.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-41d7-735b-bdce-76898f0847d2/4",
  "deckHref": "/decks/019de071-41d7-735b-bdce-76898f0847d2",
  "deckJsonHref": "/decks/019de071-41d7-735b-bdce-76898f0847d2.json",
  "deckAnchorHref": "/decks/019de071-41d7-735b-bdce-76898f0847d2#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.52,
        "y": 0.15
      },
      "kind": "callout",
      "text": "Raised $320M to date from top-tier investors",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e78d15c-f1fe-4080-bce6-665d43c00d9a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.45,
        "x": 0.52,
        "y": 0.25
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dcc730bb-8db3-4bfb-99c6-acaabd2ad0d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.45,
        "x": 0.03,
        "y": 0.25
      },
      "kind": "list",
      "text": "Founded by Jonathan Lim, MD, and Kevan Shokat, PhD, in July 2018 around disruptive idea to target the active state of RAS. Modality-agnostic pipeline of 11 targeted therapy programs singularly focused on shutting down the RAS/MAPK pathway.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53683452-f4cd-40ac-8829-b8c34148bc78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.42,
        "x": 0.06,
        "y": 0.45
      },
      "kind": "list",
      "text": "Developing our first, innovative MAPKlamp comprising ERAS-007 ERK inhibitor and ERAS-601 SHP2 inhibitor. Advancing ERAS-1 CNS-penetrant KRAS G12C inhibitor program into IND-enabling studies in H2 2021. Filing IND for ERAS-801 CNS-penetrant EGFR inhibitor.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8932b469-e07b-41fa-8f3a-f1ba8ca44ae8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "Our Vision is to one day erase cancer in at least 100,000 patients annually as a leading global oncology company",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0fa20b93-e9e7-4777-88a5-de566a0b3221",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.15,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "CNS = central nervous system. Defined by number of patients who are alive and free of cancer or free from cancer progression 2 years after starting treatment on an Erasca regimen.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "25685e81-a548-43c8-98a7-d5b31ee491a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Our name is our mission: to erase cancer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f238165-d424-4cde-849b-f6a492766f83",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "064ea893-7d18-428c-ac1e-606fb9837d89",
      "evidence": "Our Vision is to one day erase cancer in at least 100,000 patients annually as a leading global oncology company",
      "confidence": 0.7
    },
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "92ae26b8-31fa-40f9-b8ff-1d2e721192ec",
      "evidence": "Raised $320M to date from top-tier investors",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}